启迪药业: 关于控股股东所持股份可能被司法拍卖暨公司控制权或将发生变更的进展公告

Group 1 - The controlling shareholder of Qidi Pharmaceutical, Qidi Technology Service Co., Ltd., is set to auction 58,606,962 shares, which represents 24.47% of the company's total equity, on November 28-29, 2024 [1][2] - The auction has been temporarily suspended due to objections from interested parties related to a financial loan dispute with Agricultural Bank of China [2] - If the auction proceeds successfully, Qidi Technology Service's shareholding will drop significantly, potentially leading to a change in the company's control [2][3] Group 2 - Currently, Qidi Technology Service and its concerted action party hold a total of 63,151,413 shares, accounting for 26.37% of the total equity [2] - Post-auction, if successful, Qidi Technology Service will no longer hold shares, and its voting rights will decrease to 4,544,451 shares, or 1.90% of the total equity [2][3] - The company asserts that the auction will not significantly impact its operations or governance, as it operates independently from its controlling shareholder [3]